New report from The Royal College of Physician: positive impact of E-Cigarettes

The Royal College of Physicians has assessed the available evidence on the use of e-cigarettes, from health effects to the issue of youth vaping, publishing a report with over 50 recommendations. It concluded that e-cigarettes represent a valuable aid in smoking cessation, but that much more can and should be done to reduce their appeal, availability and affordability to people who do not smoke, including children and young people, and reduce environmental harms. 

Continue ReadingNew report from The Royal College of Physician: positive impact of E-Cigarettes

Cochrane: Some medicines and e-cigarettes can help people to quit smoking

According the authors, for every 100 people, 10 to 19 are likely to quit using an e-cigarette; 12 to 16 using varenicline; and 10 to 18 using cytisine. This is compared to the 6 in 100 people likely to quit when using no medicine/e-cigarette or placebo. People using two forms of nicotine replacement therapy at the same time, for example, a combination of nicotine patch and nicotine gum, seemed to have similar rates of quitting to people using e-cigarettes, varenicline and cytisine.

Continue ReadingCochrane: Some medicines and e-cigarettes can help people to quit smoking

In Silico review: ecig add no additional cardiovascular health risks

The research covered 25 studies comprising 1,810 participants who smoked. The authors found that nearly two thirds of the tests analyzed showed e-cigarettes do not bring any additional harm to a smoker’s health, specifically in relation to heart rate, blood pressure and cardiovascular test. In fact, researchers evaluated evidence from two clinical studies that showed that the use of e-cigarettes could lead to a potential benefit. For example, participants with hypertension experienced a clinically significant reduction in systolic blood pressure after one year of electronic nicotine delivery systems use.

Continue ReadingIn Silico review: ecig add no additional cardiovascular health risks

Impact of ENDS on oxidative stress: a Replica project review

An independent review by the Replica project team examines the impact of tobacco smoke and electronic nicotine delivery systems use on oxidative stress, the precursor of the so-called tobacco related diseases (respiratory and cardiovascular diseases, tumors). To date, the scientific evidence available constitutes a puzzle of information, which, despite experimental and procedural limitations of international studies , already shows a reduced impact of ENDS on oxidative stress compared to cigarette smoking, even if some research have concluded that they do not completely eliminate it, leaving the question still pending 

Continue ReadingImpact of ENDS on oxidative stress: a Replica project review

Study showed that vaping is linked to respiratory symptoms but according to CoEHAR researchers: “No causality proved”

The prestigious American Journal of Respiratory and Critical Care Medicine published a comment by researchers from CoEHAR and the University of Messina regarding a US studies that concluded that “former and current e-cigarette use was associated with higher odds of developing wheezing-related respiratory symptoms”. According to the Italian authors “the significance of the findings needs careful review”.

Continue ReadingStudy showed that vaping is linked to respiratory symptoms but according to CoEHAR researchers: “No causality proved”

New Scientific Review Gives Green Light for Smokers to Switch to Vaping With Confidence

Lack of Clear Communications About E-Cigarettes Could Lead to More Deaths Due to Combustible Cigarette Smoking August 12, 2019 (Catania, Italy) –  Smokers should be confident that vaping with e-cigarettes…

Continue ReadingNew Scientific Review Gives Green Light for Smokers to Switch to Vaping With Confidence